Ella:
As far as what else investors may look at in Clorox, the stock is valued at almost 24 times expected 2016 earnings and roughly 22 times expected 2017 earnings.
Lizzie:
All in all, Clorox is targeting net sales growth of 3% to 5% annually, expanding its EBIT margin by 25 to 50 basis points annually and generating free cash flow of 10% to 12% of sales annually.
Selina:
That strategy was actually introduced back in 2013. While these efforts are not set in stone and may change, Clorox included its four highest-value opportunities or strategy accelerators.
Tisa:
Analysts also have a mixed picture, with the consensus view at a lower price than the current share price.
Renea:
The caution would be over a premium market valuation and a lower dividend than peers.
Asuncion:
There is at least some reason to be concerned here, but before anyone hits a panic button, note that Clorox has some of the best brands among peers and it is a highly defensive stock.
Adela:
So, should Clorox be issuing (or reissuing) very long-term stated growth and strategic plans?
Shaunte:
That being said, companies issuing five-year or longer strategic and growth plans often find themselves unable to meet expectations, even if they are low, due to unexpected events.
Merissa:
The table below presents the reconciliation of the non-GAAP financial measure for currency-neutral sales to the most directly comparable financial measures calculated in accordance with GAAP and other supplemental information.
Lashandra:
See the end of this press release for the reconciliation.
Clorox Company (NYSE:CLX)
//stockhand.net/us/?q=nyse%3Aclx&id=682624
No comments:
Post a Comment